Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
371M
-
Number of holders
-
302
-
Total 13F shares, excl. options
-
176M
-
Shares change
-
+169M
-
Total reported value, excl. options
-
$4.52B
-
Value change
-
+$4.34B
-
Put/Call ratio
-
2.27
-
Number of buys
-
286
-
Number of sells
-
-9
-
Price
-
$25.67
Significant Holders of Bausch Health Companies Inc. - Common Stock, no par value (BHC) as of Q3 2018
357 filings reported holding BHC - Bausch Health Companies Inc. - Common Stock, no par value as of Q3 2018.
Bausch Health Companies Inc. - Common Stock, no par value (BHC) has 302 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 176M shares
of 371M outstanding shares and own 47.33% of the company stock.
Largest 10 shareholders include PAULSON & CO. INC. (20.8M shares), ValueAct Holdings, L.P. (18M shares), Vanguard Group Inc (8.69M shares), Connor, Clark & Lunn Investment Management Ltd. (8.38M shares), WELLINGTON MANAGEMENT GROUP LLP (7.86M shares), NOMURA HOLDINGS INC (5.83M shares), DIMENSIONAL FUND ADVISORS LP (5.28M shares), MILLER VALUE PARTNERS, LLC (4.93M shares), BANK OF MONTREAL /CAN/ (3.68M shares), and GLENVIEW CAPITAL MANAGEMENT, LLC (3.53M shares).
This table shows the top 302 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.